| Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA MC Liu, GR Oxnard, EA Klein, C Swanton, MV Seiden, MC Liu, ... Annals of Oncology 31 (6), 745-759, 2020 | 987 | 2020 |
| Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor B Roux, C Vaganay, JD Vargas, G Alexe, C Benaksas, B Pardieu, ... Science translational medicine 13 (587), eabg1168, 2021 | 33 | 2021 |
| Combination of the NS3/4A protease inhibitor ITMN-191 (R7227) with the active moiety of the NS5B inhibitors R1626 or R7128 enhances replicon clearance and reduces the emergence … H Tan, S Rajyaguru, T Wu, M McCown, S Ali, WR Jiang, M Otto, P Furman, ... The 59th Annual Meeting of the American Association for the Study of Liver …, 2008 | 17 | 2008 |
| A phase 1, open label, dose escalation study of MGD009, a humanized B7-H3 x CD3 DART protein, in combination with MGA012, an anti-PD-1 antibody, in patients with relapsed or … S Shankar, AI Spira, J Strauss, L Liu, R La Motte-Mohs, T Wu, S Johnson, ... Journal of Clinical Oncology 36 (15_suppl), TPS2601-TPS2601, 2018 | 14 | 2018 |
| Tumor area and microscopic extent of invasion to determine circulating tumor DNA fraction in plasma and detectability of colorectal cancer (CRC). J Bredno, J Lipson, O Venn, S Gross, AP Fields, JF Beausang, Q Liu, ... Journal of Clinical Oncology 38 (4_suppl), 243-243, 2020 | 6 | 2020 |
| Prospective evaluation of cell-free DNA fragmentomes for lung cancer detection PJ Mazzone, KK Wong, JCJ Tsay, HI Pass, A Vachani, A Ryan, J Carey, ... Cancer Research 83 (7_Supplement), 5766-5766, 2023 | 2 | 2023 |
| Cell-Free DNA Fragmentomes in the Diagnostic Evaluation of Patients With Symptoms Suggestive of Lung Cancer AIC Leal, D Mathios, D Jakubowski, JS Johansen, A Lau, T Wu, ... Chest 164 (4), 1019-1027, 2023 | 1 | 2023 |
| Abstract CT021: Prediction of cancer and tissue of origin in individuals with suspicion of cancer using a cell-free DNA multi-cancer early detection test DD Thiel, X Chen, KN Kurtzman, J Yecies, T Wu, Q Zhang, H Liu, N Zhang, ... Cancer Research 80 (16_Supplement), CT021-CT021, 2020 | 1 | 2020 |
| Prediction of cancer and tissue of origin in individuals with suspicion of cancer using a cell-free DNA multi-cancer early detection test DD Thiel, X Chen, KN Kurtzman, J Yecies, T Wu, Q Zhang, H Liu, N Zhang, ... CANCER RESEARCH 80 (16), 2020 | 1 | 2020 |
| PROSPECTIVE EVALUATION OF CELL-FREE DNA FRAGMENTATION PROFILES FOR LUNG CANCER DETECTION PJ Mazzone, KK Wong, J Tsay, A Vachani, J Thompson, A Ryan, J Carey, ... CHEST 164 (4), A4167-A4169, 2023 | | 2023 |
| Prospective evaluation of cell-free DNA fragmentation profiles for lung cancer detection. KK Wong, PJ Mazzone, JC Tsay, HI Pass, A Vachani, JC Thompson, ... Journal of Clinical Oncology 41 (16_suppl), e20521-e20521, 2023 | | 2023 |
| Analysis of cell-free DNA (cfDNA) fragmentomes and prediction scores across distinct molecular subtypes. M Schuurbiers, A Leal, D Aghamirzaie, B Chesnick, E Peters, T Wu, ... Journal of Clinical Oncology 41 (16_suppl), e15029-e15029, 2023 | | 2023 |
| Abstract LB208: A potent macrophage switching drug D-4559 reduces tumor GROWTH in a hepatocellular carcinoma mouse model NG Avci, T Wu, SE Alters, E Zhang, J Liu, D Huang, NL Moan, JL Cleland Cancer Research 83 (8_Supplement), LB208-LB208, 2023 | | 2023 |
| Cell-free DNA (cfDNA) fragmentomes predict tumor burden in metastatic colorectal cancer (mCRC). A Leal, I van't Erve, K Lumbard, L Keefer, J Carey, T Wu, D Jakubowski, ... Journal of Clinical Oncology 40 (16_suppl), 3541-3541, 2022 | | 2022 |
| Performance of a Multi-Cancer Detection Test as a Tool for Diagnostic Resolution of Symptomatic Gynecological Cancers MC Liu, AH Bryce, MV Seiden, D Thiel, D Richards, C Becerra, ... Journal of Minimally Invasive Gynecology 28 (11), S45-S46, 2021 | | 2021 |
| Multi-Cancer Detection Test to Aid Clinically Presenting Head and Neck Cancer Diagnosis AH Bryce, MC Liu, MV Seiden, DD Thiel, D Richards, C Becerra, ... Annual Meeting & OTO Experience, 2021 | | 2021 |
| Performance of a Cell-Free DNA-Based Multi-Cancer Detection Test as a Tool for Diagnostic Resolution of Symptomatic Cancers AH Bryce, MC Liu, MV Seiden, DD Thiel, D Richards, C Becerra, ... Cancer Research 81 (13), 2021 | | 2021 |
| Tu1836 TUMOR AREA AND MICROSCOPIC EXTENT OF INVASION DETERMINE CIRCULATING TUMOR CELL-FREE DNA FRACTION IN PLASMA AND DETECTABILITY OF COLORECTAL CANCER J Bredno, J Lipson, O Venn, S Gross, AP Fields, J Beausang, Q Liu, ... Gastroenterology 158 (6), S-1181, 2020 | | 2020 |
| Identifying mechanisms of macrophage-induced metastasis in pancreatic ductal adenocarcinoma. TJ Wu Journal of Clinical Oncology 37 (15_suppl), e15705-e15705, 2019 | | 2019 |
| Utilization of K48 poly-ubiquitin modulation as a biomarker of target engagement for a protein homeostasis inhibitor in the clinic: Preclinical validation with CB-5083, a first … MK Menon, F Soriano, S Wong, E Valle, S Djakovic, B Kumar, B Yao, ... Cancer Research 76 (14_Supplement), 4541-4541, 2016 | | 2016 |
